🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

James L. Abbruzzese

Duke Medical Center

ORCID: 0000-0001-9223-2965

Also affiliated with Duke Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial.

17 citations

Dan Wang, Yongde Luo, Liang‐Hao Hu, Ya‐Wei Bi, Jun‐Tao Ji +12 more

13 citations

Xiaokun Li, Jianjia Ma, James L. Abbruzzese, Weiqin Lu, Yongde Luo

11 citations

Jun‐Tao Ji, Jianjia Ma, Dan Wang, Muyun Liu, James Xianxing Du +8 more

0 citations

Donald P. Lesslie, Nikolas A. Dallas, Serk In Park, Marjorie Johnson, Nila U. Parikh +6 more

22 citations

Danwen Qian, Hongliang Liu, James L. Abbruzzese, Sheng Luo, Kyle M. Walsh +2 more